TCTR20190218006招募中4 期
Oral indomethacin for the prevention of post-ERCP pancreatitis: A Randomized Controlled Trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Patient (aged 18-85 years) with naïve papilla planned for diagnostic or therapeutic ERCP were eligible for enrollment in the study
排除标准
- •contraindication to ERCP, allergy to NSAIDs, contraindication to NSAIDs (including gastrointestinal hemorrhage within 4 weeks or renal dysfunction with serum creatinine > 1.4 mg/dl), previous biliary sphincterotomy, active pancreatitis, previous post-ERCP pancreatitis, active cardiovascular or cerebrovascular disease, unwilling or inability to provide consent and pregnant or breastfeeding women.
研究者
相似试验
已完成
4 期
Rectal Indomethacin to Prevent Post ESWL-pancreatitisPancreatitisNCT02797067Changhai Hospital1,370
招募中
Unknown
Comparison of two doses of Dexmedetomidine for preventing delirium in womeCTRI/2023/05/053201niversity College of Medical Siences
招募中
3 期
Treatment with Oral Diazepam for Prevention of Recurrence of Seizures following DTP and MMR VaccinatioIRCT20210619051624N1Ahvaz University of Medical Sciences30
已完成
2 期
Rectal Indomethacin in the Prevention of Post-ERCP PancreatitisPost-ERCP PancreatitisNCT01912716Indiana University1,037
招募中
2 期
Role of indomethacin suppository as a possible means to reduce complications related to Pancreatoduodenectomy.CTRI/2020/09/028027Institute of Liver and Biliary Sciences